Cowealth Medical Holding Co., Ltd.

TPEX:4745 Stock Report

Market Cap: NT$1.8b

Cowealth Medical Holding Past Earnings Performance

Past criteria checks 1/6

Cowealth Medical Holding's earnings have been declining at an average annual rate of -30.5%, while the Healthcare industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 5.4% per year. Cowealth Medical Holding's return on equity is 3%, and it has net margins of 1.2%.

Key information

-30.5%

Earnings growth rate

-30.1%

EPS growth rate

Healthcare Industry Growth9.1%
Revenue growth rate5.4%
Return on equity3.0%
Net Margin1.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Is Cowealth Medical Holding Co., Ltd. (GTSM:4745) A Risky Dividend Stock?

Apr 06
Is Cowealth Medical Holding Co., Ltd. (GTSM:4745) A Risky Dividend Stock?

Cowealth Medical Holding's(GTSM:4745) Share Price Is Down 43% Over The Past Five Years.

Mar 16
Cowealth Medical Holding's(GTSM:4745) Share Price Is Down 43% Over The Past Five Years.

Will Cowealth Medical Holding (GTSM:4745) Multiply In Value Going Forward?

Feb 22
Will Cowealth Medical Holding (GTSM:4745) Multiply In Value Going Forward?

Does The Market Have A Low Tolerance For Cowealth Medical Holding Co., Ltd.'s (GTSM:4745) Mixed Fundamentals?

Feb 01
Does The Market Have A Low Tolerance For Cowealth Medical Holding Co., Ltd.'s (GTSM:4745) Mixed Fundamentals?

What To Know Before Buying Cowealth Medical Holding Co., Ltd. (GTSM:4745) For Its Dividend

Jan 06
What To Know Before Buying Cowealth Medical Holding Co., Ltd. (GTSM:4745) For Its Dividend

A Look At Cowealth Medical Holding's (GTSM:4745) Share Price Returns

Dec 13
A Look At Cowealth Medical Holding's (GTSM:4745) Share Price Returns

Returns On Capital At Cowealth Medical Holding (GTSM:4745) Paint An Interesting Picture

Nov 23
Returns On Capital At Cowealth Medical Holding (GTSM:4745) Paint An Interesting Picture

Revenue & Expenses Breakdown
Beta

How Cowealth Medical Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:4745 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 234,8135670614
30 Sep 235,0748270113
30 Jun 235,3667970413
31 Mar 235,4529572313
31 Dec 225,6269472212
30 Sep 225,48411774610
30 Jun 225,3011247247
31 Mar 225,3751427322
31 Dec 215,1401397180
30 Sep 215,343937480
30 Jun 215,125907600
31 Mar 214,9961367020
31 Dec 204,7221246860
30 Sep 204,4011526240
30 Jun 204,4081856190
31 Mar 204,4292556320
31 Dec 194,6652806310
30 Sep 194,4963036250
30 Jun 194,4703096150
31 Mar 194,1022925390
31 Dec 183,8992865250
30 Sep 183,7702814990
30 Jun 183,4912544880
31 Mar 183,2141735470
31 Dec 173,0371745380
30 Sep 172,9521765270
30 Jun 172,8611755300
31 Mar 172,9081555540
31 Dec 162,9661755570
30 Sep 163,0593095970
30 Jun 163,1313075990
31 Mar 163,1383056110
31 Dec 153,2753476760
30 Sep 153,2372546400
30 Jun 153,2182936470
31 Mar 153,2383206480
31 Dec 143,1763156180
30 Sep 142,9542826140
30 Jun 142,8072785800
31 Mar 142,7552925930
31 Dec 132,5802735790
30 Sep 132,4462525710
30 Jun 132,4622385990

Quality Earnings: 4745 has high quality earnings.

Growing Profit Margin: 4745's current net profit margins (1.2%) are lower than last year (1.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4745's earnings have declined by 30.5% per year over the past 5 years.

Accelerating Growth: 4745's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4745 had negative earnings growth (-40.8%) over the past year, making it difficult to compare to the Healthcare industry average (7.6%).


Return on Equity

High ROE: 4745's Return on Equity (3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.